Drug Manufacturers—General Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12 |  LLY Eli Lilly and Company Common Stock | 1169.93 USD | -1.55% | +1.53% | +3.99% | +36.50% | 1.10 T USD | ||
| 20 |  JNJ Johnson & Johnson Common Stock | 256.49 USD | -0.71% | -1.00% | -5.18% | +33.58% | 618.11 B USD | ||
| 23 |  ABBV AbbVie Inc. Common Stock | 272.42 USD | +0.41% | +5.17% | +8.43% | +17.57% | 481.40 B USD | ||
| 35 |  MRK Merck & Company, Inc. Common Stock | 142.40 USD | -0.25% | -0.95% | -3.66% | +62.21% | 351.33 B USD | ||
| 47 |  NVS Novartis AG | 143.12 USD | -0.10% | +1.18% | +3.13% | +8.58% | 273.09 B USD | ||
| 66 |  AMGN Amgen Inc. - Common Stock | 407.44 USD | -1.37% | -0.66% | +5.05% | +37.57% | 220.28 B USD | ||
| 82 |  GILD Gilead Sciences, Inc. - Common Stock | 147.10 USD | +0.17% | -0.41% | +1.40% | +25.27% | 182.40 B USD | ||
| 99 |  PFE Pfizer, Inc. Common Stock | 27.83 USD | -0.57% | -0.96% | +0.29% | +10.04% | 158.62 B USD | ||
| 125 |  BMY Bristol-Myers Squibb Company Common Stock | 59.56 USD | -0.20% | -2.28% | -8.11% | +33.72% | 121.66 B USD | ||
| 154 |  GSK GSK plc American Depositary Shares | 46.52 USD | -1.06% | -1.13% | -4.02% | +6.09% | 100.38 B USD | ||
| 161 |  SNY Sanofi - American Depositary Shares | 40.23 USD | +0.07% | +1.46% | -6.14% | -17.86% | 98.12 B USD | ||
| 371 |  ONC BeOne Medicines Ltd - American Depositary Shares | 350.13 USD | -3.82% | -0.38% | +2.51% | +10.91% | 39.81 B USD | ||
| 423 |  BIIB Biogen Inc. - Common Stock | 218.43 USD | -1.67% | -1.98% | +4.05% | +45.62% | 32.27 B USD | ||
| 1220 |  CGON CG Oncology, Inc. - Common stock | 63.26 USD | +1.41% | -8.78% | -10.79% | +45.22% | 5.61 B USD | ||
| 1264 |  MANE Veradermics, Incorporated Common Stock | 126.68 USD | +13.94% | +5.28% | +28.57% | +283.88% | 5.29 B USD | ||
| 1286 |  ORKA Oruka Therapeutics, Inc. - Common Stock | 77.28 USD | -2.79% | -9.66% | -14.33% | +140.97% | 5.12 B USD | ||
| 1534 |  OGN Organon & Co. Common Stock | 13.76 USD | -0.15% | +0.29% | +0.73% | +89.53% | 3.61 B USD | ||
| 1780 |  MBX MBX Biosciences, Inc. - Common Stock | 53.25 USD | -2.37% | -10.17% | -14.70% | +234.91% | 2.56 B USD | ||
| 1985 |  PVLA Palvella Therapeutics, Inc. - Common Stock | 131.34 USD | +0.57% | -2.82% | -11.51% | +77.85% | 1.89 B USD | ||
| 2025 |  GENB Generate Biomedicines, Inc. - Common Stock | 13.99 USD | +3.10% | +0.43% | -8.68% | -6.73% | 1.80 B USD |
Noticias Drug Manufacturers—General Stocks
SOPHiA GENETICS y Myriad Genetics colaboran para avanzar en una nueva tecnología de puntuación de inestabilidad genómica específica para el cáncer de próstata
Cantor Fitzgerald eleva el precio objetivo de Pfizer por sus perspectivas
Northern Discovery adquirirá el proyecto de cobre y oro Cibola en Columbia Británica
Cantor Fitzgerald rebaja el precio objetivo de Bristol-Myers Squibb a 53 dólares
Cantor Fitzgerald eleva el precio objetivo de Amgen por la solidez de su cartera
Cantor Fitzgerald eleva el precio objetivo de Merck ante las perspectivas para 2027
Cantor Fitzgerald eleva el precio objetivo de Eli Lilly por tendencias de demanda
Gainers Drug Manufacturers—General Stocks
 LIMNW Liminatus Pharma, Inc. - Warrants | 0.0497 | +34.32% |
MANE Veradermics, Incorporated Common Stock | 126.68 | +13.94% |
 OSTX OS Therapies Incorporated Common Stock | 1.62 | +5.88% |
 KAPA Kairos Pharma, Ltd. Common Stock | 0.93 | +5.68% |
 CBIO Crescent Biopharma, Inc. - Common Stock | 14.12 | +4.67% |
GENB Generate Biomedicines, Inc. - Common Stock | 13.99 | +3.10% |
 QCLS Q/C Technologies, Inc. - Common Stock | 0.64 | +1.59% |
CGON CG Oncology, Inc. - Common stock | 63.26 | +1.41% |
Losers Drug Manufacturers—General Stocks
 MDCX Medicus Pharma Ltd. - Common Stock | 0.10 | -37.50% |
 APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 5.43 | -22.09% |
 ERNAW Ernexa Therapeutics Inc. - Warrants | 0.0319 | -16.05% |
 SCLX Scilex Holding Company - Common Stock | 2.96 | -15.19% |
 IBO Impact BioMedical, Inc. Common Stock | 4.12 | -9.25% |
 PPCB Propanc Biopharma, Inc. - Common Stock | 0.47 | -6.00% |
 DCOY Decoy Therapeutics Inc. - Common Stock | 1.52 | -5.59% |
 VIVS VivoSim Labs, Inc. - Common Stock | 0.18 | -5.26% |